Journey Medical Corporation (DERM) Earnings Call Analysis
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Earnings Reports
-
Journey Medical (DERM) Q1 2026: Ambrosie Revenue Jumps 200% as Payer Access Hits 169 Million Lives
May 14, 2026
-
Journey Medical (DERM) Q4 2025: MROSI Scripts Annualize at 126,000, Driving Margin Expansion and Brand Penetration
March 26, 2026
-
Journey Medical (DERM) Q3 2025: Amrosi Prescriptions Jump 146%, Driving Operating Leverage
November 13, 2025
-
Journey Medical (DERM) Q2 2025: Amrosi Drives $2.8M Launch, Lifts Gross Margin to 67%
August 13, 2025